Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | GALR3 | O60755 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.70 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.70 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.70 |
| ▸ | HTR1A | P08908 | 1/20 | 0.70 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.70 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.70 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.70 |
| ▸ | DRD1 | P21728 | 1/20 | 0.70 |
| ▸ | HTR7 | P34969 | 1/20 | 0.70 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.70 |
| ▸ | DRD3 | P35462 | 1/20 | 0.70 |
| ▸ | RAB9A | P51151 | 1/20 | 0.70 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etilefrine SCHEMBL30510958 | 1.00 | HIF1A (1.00) | HIF1ALMNAGALR3ADRB2ADRB1 | |
| Etilefrine SCHEMBL29603739 | 1.00 | HIF1A (1.00) | HIF1ALMNAGALR3ADRB2ADRB1 | |
| Etilefrine SCHEMBL31204243 | 0.98 | HIF1A (0.97) | HIF1ALMNAGALR3ADRB2ADRB1 | |
| Etilefrine SCHEMBL207591 | 0.98 | HIF1A (0.97) | HIF1ALMNAGALR3ADRB2ADRB1 | |
| Etilefrine SCHEMBL10753730 | 0.89 | HIF1A (0.78) | HIF1ALMNAGALR3ADRB2ADRB1 | |
| Etilefrine SCHEMBL2733170 | 0.89 | HIF1A (0.78) | HIF1ALMNAGALR3ADRB2ADRB1 | |
| Etilefrine SCHEMBL5488709 | 0.89 | HIF1A (0.78) | HIF1ALMNAGALR3ADRB2ADRB1 | |
| SCHEMBL19329764 | 0.84 | HIF1A (0.72) | HIF1ALMNAGALR3ADRB2ADRB1 | |
| SCHEMBL16709940 | 0.83 | LMNA (0.71) | HIF1ALMNAGALR3ADRB2ADRB1 | |
| Phenylephrine SCHEMBL4711 | 0.82 | HIF1A (1.00) | HIF1ALMNAGALR3ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2423 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704839-A2 | IMIDAZOLE CONTAINING COMPOUNDS, DERIVATIVES THEREFORE, AND USES THEREOF | ALPHERABIO LLC (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2025265094-A1 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-26 | — | — | WO | claimed |
| EP-4599048-A1 | COMPOSITIONS AND METHODS FOR SMALL MOLECULE BASED EXPANSION OF PLURIPOTENT STEM CELLS | Trailhead Biosystems Inc. (US) | 2025-08-13 | — | — | EP | claimed |
| US-20250213647-A1 | CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE | UNIVERSITY OF SOUTH FLORIDA | 2025-07-03 | — | — | US | claimed |
| EP-4569090-A2 | METHODS AND COMPOSITIONS FOR GENERATING OLIGODENDROCYTE PROGENITOR CELLS | Trailhead Biosystems Inc. (US) | 2025-06-18 | — | — | EP | claimed |
| US-20250108056-A1 | SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE | HAMDAN MOHAMED HUSSEIN (US) | 2025-04-03 | — | — | US | claimed |
| US-20240398729-A1 | Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage Disorders | DUKE UNIVERSITY (US) | 2024-12-05 | — | — | US | claimed |
| EP-4157451-B1 | SUBLINGUAL FORMULATION FOR HYPOTENSION AND SYNCOPE | HAMDAN MOHAMED HUSSEIN (US) | 2024-12-04 | — | — | EP | claimed |
| WO-2024226608-A2 | IMIDAZOLE CONTAINING COMPOUNDS, DERIVATIVES THEREFORE, AND USES THEREOF | AGLAEAPHARMA INC. (US) | 2024-10-31 | — | — | WO | claimed |
| US-20240316057-A1 | PULSATILE RELEASE CAFFEINE FORMULATION | GALVENTA AG (TR) | 2024-09-26 | — | — | US | claimed |
| WO-1997037629-A1 | PROCESS FOR ENCAPSULATION OF CAPLETS IN A CAPSULE AND SOLID DOSAGE FORMS OBTAINABLE BY SUCH PROCESS | WARNER-LAMBERT COMPANY (US) | 1997-10-16 | — | — | WO | claimed |
| EP-0797424-A1 | PROCESS FOR ENCAPSULATION OF CAPLETS IN A CAPSULE AND SOLID DOSAGE FORMS OBTAINABLE BY SUCH PROCESS | WARNER-LAMBERT COMPANY (US) | 1997-10-01 | — | — | EP | claimed |
| WO-1996018370-A1 | PROCESS FOR ENCAPSULATION OF CAPLETS IN A CAPSULE AND SOLID DOSAGE FORMS OBTAINABLE BY SUCH PROCESS | WARNER-LAMBERT COMPANY (US) | 1996-06-20 | — | — | WO | claimed |
| WO-1995032981-A1 | NOVEL GLYCOSIDE COMPOUNDS AND PRODUCTION AND USE THEREOF | HARRIER, INC. (US) | 1995-12-07 | — | — | WO | claimed |
| EP-0480934-B1 | A SLIMMING PHARMACEUTICAL COMPOSITION | NYCOMED DAK AS (DK) | 1994-06-29 | — | — | EP | claimed |
| EP-0480934-A1 | A SLIMMING PHARMACEUTICAL COMPOSITION. | DAK LAB AS (DK) | 1992-04-22 | — | — | EP | claimed |
| WO-1991000730-A1 | A SLIMMING PHARMACEUTICAL COMPOSITION | DAK-LABORATORIET A/S (DK) | 1991-01-24 | — | — | WO | claimed |
| EP-0213108-A2 | Pharmaceutical preparation containing an antihypotonic as the active agent | Burghart, Kurt, Dr. (DE) | 1987-03-04 | — | — | EP | claimed |
| EP-0162320-A1 | Use of etilefrine or of pivalate of etilefrine in the preparation of a drug for the prolonged treatment of disturbances of the blood supply not caused by hypertension | Klinge Pharma GmbH (DE) | 1985-11-27 | — | — | EP | claimed |
| EP-0152379-A2 | Process for preparing pharmaceutical compositions containing unilamellar liposomes | CIBA-GEIGY AG (CH) | 1985-08-21 | — | — | EP | claimed |